Results 11 to 20 of about 682,778 (301)

Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension [PDF]

open access: yes, 2012
Objectives: Pulse wave velocity (PWV) is a surrogate end-point for cardiovascular morbidity and mortality. A plasma glucose value $155 mg/dl for the 1-hour post-load plasma glucose during an oral glucose tolerance test (OGTT) is able to identify ...
Arturi, F   +8 more
core   +15 more sources

Dietary sodium sources in hypertensive patients

open access: yesArterial Hypertension, 2023
BACKGROUND: Reducing dietary salt intake is the method recommended by the experts as the non-pharmacological treatment of hypertension. The purpose of this study was to evaluate the amount of dietary sodium intake by hypertensive patients and to analyze ...
Dariusz Stąpor   +5 more
doaj   +1 more source

Pulmonary arterial hypertension

open access: yesMedicina, 2007
Pulmonary arterial hypertension is a life-threatening, progressive disorder of pulmonary blood vessels leading to an increase in pressure in pulmonary artery. Diagnosis is based on a mean pulmonary artery pressure of more than 25 mmHg at rest or more than 30 mmHg during exercise. No cure exists for it yet.
José Luis, Puglisi   +3 more
  +7 more sources

Unattended automated office blood pressure measurement — current evidence and the role in clinical practice

open access: yesArterial Hypertension, 2021
Arterial hypertension is a leading preventable cardiovascular risk factor. The definition and thresholds for the diagnosis of hypertension vary between European and American guidelines.
Marek Stopa   +2 more
doaj   +1 more source

Myocardial infarction caused by Graves’ disease

open access: yesEndokrynologia Polska, 2021
Not required for Clinical Vignette.
Marek Kuch   +3 more
doaj   +1 more source

Pulmonary arterial hypertension [PDF]

open access: yesBreathe, 2005
Key pointsPAH is defined by RHC showing a pre-capillary PH.Clinical suspicion of PH should arise in the case of symptoms such as dyspnoea without overt signs of specific heart or lung disease.RHC is required to confirm the diagnosis of PAH, to assess the severity of the haemodynamic impairment and to test the vasoreactivity of the pulmonary circulation.
D, Montani   +5 more
openaire   +3 more sources

Metformin reverses development of pulmonary hypertension via aromatase inhibition [PDF]

open access: yes, 2016
Females are more susceptible to pulmonary arterial hypertension than males, although the reasons remain unclear. The hypoglycemic drug, metformin, is reported to have multiple actions, including the inhibition of aromatase and stimulation of AMP ...
Dean, Afshan   +4 more
core   +2 more sources

MicroRNA-483 amelioration of experimental pulmonary hypertension. [PDF]

open access: yes, 2020
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit.
Bai, Liang   +22 more
core   +1 more source

Exploratory analysis of the neutrophil to lymphocyte ratio in patients with pulmonary arterial hypertension

open access: yesBMC Pulmonary Medicine, 2017
Background Chronic inflammation emerges as a feature of the pathogenesis of pulmonary arterial hypertension (PAH) in experimental models. Alterations of circulating cell subsets have been observed in patients with PAH.
Lars Harbaum   +9 more
doaj   +1 more source

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundAtrial fibrillation (AF) is a common arrhythmia with increasing prevalence with respect to age and comorbidities. AF may influence the prognosis in patients hospitalized with Coronavirus disease 2019 (COVID-19).
Michał Terlecki   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy